UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) January 13, 1997
Unimed Pharmaceuticals, Inc.
(Exact name of registrant as specified in its charter)
Delaware 0-3390 22-1685346
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
2150 East Lake Cook Rd., Buffalo Grove, IL 60089
(Address of principal executive offices)
Registrant's telephone number, including area code (847) 541-2525
<PAGE>
Item 5. Other Events
On Monday, January 13, 1997, Mr. Stephen M. Simes resigned as
President/CEO and a Director of the Company to pursue other business
interests. Dr. Robert E. Dudley, formerly Vice President of Clinical
and Regulatory Affairs, was appointed President and CEO on an
interim basis.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
UNIMED PHARMACEUTICALS, INC.
Date: January 13, 1997 By: /s/ David E. Riggs
David E. Riggs
Senior Vice President and Chief Financial Officer
